.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Dieter Henrik Heiland

Freiburg im Breisgau

Universitätsklinikum Freiburg

Further involvements

28/10/2022
11:55 – 12:05 7 Min. 3 Min.
Abstractvortrag
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy – the MecMeth/NOA-24 trial study protocol
29/10/2022
11:15 – 11:30 10 Min. 5 Min.
Abstractvortrag
Unsupervised Classification of Stimulated Raman Scattering Microscopy in Meningiomas Using Deep Convolutional Neural Networks
29/10/2022
11:40 – 11:50 7 Min. 3 Min.
Abstractvortrag
Spectro-genomics through integration of spatially resolved transcriptomics and Raman scattering microscopy